ARDTArdent Health, Inc.
Is it safe?
Nothing alarming, nothing pristine: comfortable debt (A) and big price swings.
Investment-grade balance sheet. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -61% · now 26% below its 52-week high.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can ARDT take a bad year?
Ardent Health, Inc. carries $377M of net debt at 1.01× EBITDA: a load its earnings can carry.
Net debt · as at Q2 2026 · under two and a half years of EBITDA, comfortable
- Net debt / EBITDA
- 1.01×
Net debt / EBITDA · 1.00× a year ago · the load is going up
- Interest cover
- 4.07×
Interest cover · operating profit covers the interest bill, with room to spare
- Annualised volatility
- 52%
Annualised volatility · roughly twice as jumpy as the market
Details›
- Total debtQ2 2026
- $1.10B
- Cash and short-term investments
- $724M
- Net debt
- $377M
- EBITDA, trailing twelve months
- $372M
- Operating profit, trailing twelve months
- $208M
- Debt / equity
- 0.82×
- Total debt / EBITDA
- 2.96×
- Annualised volatilitytwo years of daily moves
- 52%
- Worst drawdown on file
- −61%
- Below its 52-week high
- 26%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.